Bekir Melahat, Karakoç Aydıner Elif, Yıldızeli Şehnaz Olgun, Öğülür İsmail, Kocakaya Derya, Barış Safa, Eryüksel Emel, Özen Ahmet, Ceyhan Berrin Bağcı
Department of Pulmonary Medicine and Critical Care, Marmara University School of Medicine, İstanbul, Turkey.
Department of Pediatric Immunology and Allergy, Marmara University School of Medicine, İstanbul, Turkey.
Turk Thorac J. 2021 Jan;22(1):37-44. doi: 10.5152/TurkThoracJ.2020.19077. Epub 2021 Jan 1.
Bronchiectasis is characterized by chronic respiratory infection. The role of immunodeficiency in this disease is poorly studied in relation to clinical indices. The primary aim of this study was to determine the frequency of these neglected altered immune status by evaluating immunoglobulins, lymphocyte subsets, complement levels, and neutrophil function, and to assess its relationship with clinical parameters in adult patients with non-cystic fibrosis bronchiectasis (NCFB).
A total of 74 (30 men and 44 women with a mean age of 47±17 years) adult patients with stable NCFB were enrolled in this study. The bronchiectasis severity index (BSI) and FACED (F:FEV1, A: Age, C: Chronic colonization, E: Extension, D: Dyspnea) scores were assessed. Peripheral blood samples were collected for the detection of total IgG, IgA, IgM, IgE, and IgG subclasses and C3 and C4 levels. The counts of CD3, CD4, CD8, CD19, CD16/56 expressing peripheral blood lymphocytes and neutrophil oxidative function were evaluated.
In the study population, BSI and FACED severity index scores increased with longer duration of the disease (p=0.01 and p=0.040, respectively). Of the 74 patients, 27 (37%) showed humoral aberrations. The number of male patients were higher in this group (p=0.03). High serum total IgE levels were associated with high scores in BSI (moderate-severe group versus mild group, p=0.030). Patients with bronchiectasis demonstrated lower CD3+ T cell count, lower CD4+ T helper cell percentage, and lower CD4+ T cell count (p=0.031, p=0.030, p=0.029, respectively) than healthy subjects. A significant negative correlation was found between the percentage and count of CD16/56+ natural killer (NK) cells and the number of exacerbations within the past year (r=-0.230, p=0.049 and r=-0.264, p=0.023, respectively).
Humoral aberrations in adult patients with NCFB were found to be frequent. IgE levels were related to high scores for disease severity indices. Furthermore, patients with low percentage and counts of NK cells had higher rates of exacerbations. These results emphasize the importance of immune function assessment in adult patients with NCFB.
支气管扩张症的特征为慢性呼吸道感染。免疫缺陷在该疾病中的作用与临床指标相关的研究较少。本研究的主要目的是通过评估免疫球蛋白、淋巴细胞亚群、补体水平和中性粒细胞功能来确定这些被忽视的免疫状态改变的频率,并评估其与非囊性纤维化支气管扩张症(NCFB)成年患者临床参数的关系。
本研究共纳入74例(30例男性和44例女性,平均年龄47±17岁)病情稳定的成年NCFB患者。评估支气管扩张严重程度指数(BSI)和FACED(F:FEV1,A:年龄,C:慢性定植,E:病变范围,D:呼吸困难)评分。采集外周血样本以检测总IgG、IgA、IgM、IgE和IgG亚类以及C3和C4水平。评估表达外周血淋巴细胞的CD3、CD4、CD8、CD19、CD16/56计数以及中性粒细胞氧化功能。
在研究人群中,BSI和FACED严重程度指数评分随疾病持续时间延长而增加(分别为p = 0.01和p = 0.040)。74例患者中,27例(37%)出现体液异常。该组男性患者数量较多(p = 0.03)。高血清总IgE水平与BSI高评分相关(中度 - 重度组与轻度组相比,p = 0.030)。与健康受试者相比,支气管扩张症患者的CD3 + T细胞计数、CD4 + T辅助细胞百分比和CD4 + T细胞计数较低(分别为p = 0.031、p = 0.030、p = 0.029)。在CD16/56 + 自然杀伤(NK)细胞的百分比和计数与过去一年的病情加重次数之间发现显著负相关(分别为r = -0.230,p = 0.049和r = -0.264,p = 0.023)。
发现成年NCFB患者体液异常较为常见。IgE水平与疾病严重程度指数高评分相关。此外,NK细胞百分比和计数低的患者病情加重率较高。这些结果强调了免疫功能评估在成年NCFB患者中的重要性。